Biodegradable Mg-Cu alloy inhibits HBV replication and hepatocellular carcinoma progression

Area of Science:

• Biomaterials Science
• Oncology
• Virology

Background:

• Magnesium alloys are explored for bone repair and tissue engineering.
• The anticancer effects of magnesium alloys on cancer cells, including hepatocellular carcinoma (HCC), require further investigation.

Purpose of the Study:

• To investigate the biocompatibility and inhibitory effects of magnesium-copper (Mg-Cu) alloy on HCC cells.
• To evaluate the potential of Mg-Cu alloy as an anticancer and antiviral therapeutic agent.

Main Methods:

• Sample preparation and cell culture.
• Cell viability assays (CCK8), cell cycle and apoptosis analysis.
• Luciferase activity detection to assess hepatitis B virus (HBV) replication.

Main Results:

• Mg-Cu alloy significantly reduced viability of HCC cells (Huh7) and enhanced apoptosis.
• Higher concentrations of Mg-Cu alloy extract showed a more pronounced effect.
• Mg-Cu alloy demonstrated effective inhibition of HBV replication.

Conclusions:

• Mg-Cu alloy exhibits significant anticancer and antiviral properties.
• The findings support the potential application of Mg-Cu alloy in tumor therapy and as an antiviral agent.
• Further research is needed to explore clinical implications and underlying mechanisms.